Mosaic ImmunoEngineering Inc.
CPMV - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.8M
Close$
$-0.23
192.2% downside
Current Fair Value
192.2% downsideOvervalued by 192.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.80 Million |
|---|---|
| Enterprise Value | $3.30 Million |
| Earnings per Share | $-0.1 |
| Beta | -0.81 |
| Outstanding Shares | 7,236,447 |
Return
| Return on Equity | 8.78% |
|---|---|
| Return on Assets | -20968.43% |
| Return on Invested Capital | 9.77% |
Valuation & Multiples
| P/E Ratio | -0.66 |
|---|---|
| PEG | -20.88 |
| Price to Sales | - |
| Price to Book Ratio | -0.12 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.35 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.45 |
| Debt to Equity | -0.19 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Mosaic ImmunoEngineering Inc.
7 employees
CEO: Steven W. King
Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer a...